Ultragenyx Pharmaceutical (RARE) Prepaid Assets (2013 - 2026)

Ultragenyx Pharmaceutical (RARE) has reported Prepaid Assets for 14 consecutive years, with $68.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Prepaid Assets rose 13.63% year-over-year to $68.0 million; the TTM figure through Mar 2026 stood at $68.0 million (up 13.63% YoY), while the FY2025 annual figure was $61.0 million, up 52.5% from the prior year.
• Prepaid Assets grew to $68.0 million in Q1 2026 per RARE's latest filing, from $61.0 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $77.5 million in Q2 2022 and bottomed at $40.0 million in Q4 2024.
• Historically, Prepaid Assets has averaged $57.6 million across 5 years, with a median of $59.8 million in 2025.
• Annual changes were most pronounced in 2023 — Prepaid Assets plunged 35.15% — and 2025, when it soared 52.5%.
• Ultragenyx Pharmaceutical's Prepaid Assets stood at $68.9 million in 2022, then slumped by 30.92% to $47.6 million in 2023, then decreased by 15.99% to $40.0 million in 2024, then soared by 52.5% to $61.0 million in 2025, then rose by 11.48% to $68.0 million in 2026.
• Business Quant data shows RARE's Prepaid Assets at $68.0 million in Q1 2026, $61.0 million in Q4 2025, and $53.2 million in Q3 2025.